DUOX loss-of-function mutations are known in patients with very-early-onset inflammatory bowel disease (IBD)48–50, and studies from both insects and mammals show increased susceptibility to gastrointestinal infections after the knockdown of DUOX11,26. This evidence concerns the gene DUOX1 and inflammatory bowel disease.